SCHEMBL6312122

SCHEMBL6312122

Nc1nc(N)c2c(CSc3ccc4ccccc4c3)coc2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6310645 0.87 DHFR (0.47) —
SCHEMBL6311125 0.78 DHFR (0.47) —
SCHEMBL6306589 0.77 DHFR (0.57) —
SCHEMBL6390075 0.75 DHFR (0.44) —
SCHEMBL13833594 0.70 DHFR (0.47) —
SCHEMBL13833595 0.69 DHFR (0.46) —
SCHEMBL2915133 0.69 DHFR (0.46) —
SCHEMBL5861670 0.69 — —
SCHEMBL5476985 0.68 DHFR (0.49) —
SCHEMBL5476982 0.68 DHFR (0.49) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6962920-B2 Pyrimidine derivatives and methods of making and using these derivatives DUQUESNE UNIVERSITY OF THE HOLY GHOST (US) 2005-11-08 — — US disclosed
US-20040039000-A1 Novel pyrimidine derivatives and methods of making and using these derivatives GANGJEE ALEEM (US) 2004-02-26 — — US disclosed
US-6537999-B2 Furopyrimidines and pyrrolopyrimidines; treating cancer, and secondary infections caused by Pneumocystis carinii and Toxoplasmosis gondii in immunocompromised patients. DUQUESNE UNIVERSITY OF THE HOLY GHOST 2003-03-25 — — US disclosed
US-20020052384-A1 Novel pyrimidine derivatives and methods of making and using these derivatives GANGJEE ALEEM (US) 2002-05-02 — — US disclosed
Send feedback